CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0002 (-6.25%)
Aug 22, 2025, 2:33 PM EDT
CannaPharmaRX Revenue
CannaPharmaRX had revenue of $231.61K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $1.36M, up 5,168.10% year-over-year. In the year 2024, CannaPharmaRX had annual revenue of $820.14K.
Revenue (ttm)
1.36M
Revenue Growth
+5,168.10%
P/S Ratio
1.45
Revenue / Employee
52.35K
Employees
26
Market Cap
1.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 820.14K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
CannaPharmaRX News
- 3 months ago - CannapharmaRx Continues into New European Market with First Shipment Completed to Germany - Accesswire
- 9 months ago - CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy - Accesswire
- 10 months ago - CannapharmaRx to Complete Additional Shipment in November - Accesswire
- 1 year ago - CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product - Accesswire
- 1 year ago - Q1 2024 Financial Results - Accesswire
- 1 year ago - CannapharmaRx Pays Off Convertible Notes - Accesswire
- 1 year ago - CannapharmaRx Receives First Purchase Order and Begins Shipment of Product - Accesswire
- 1 year ago - CannaPharmaRx Completes First Harvests - Accesswire